The impact of technological convergence on firms' product portfolio strategy: an information-based imitation approach

2015 ◽  
Vol 47 (1) ◽  
pp. 17-35 ◽  
Author(s):  
Claudio Giachetti ◽  
Giovanni Battista Dagnino

2021 ◽  
Vol 1 ◽  
pp. 2791-2800
Author(s):  
Jarkko Pakkanen ◽  
Teuvo Heikkinen ◽  
Nillo Adlin ◽  
Timo Lehtonen ◽  
Janne Mämmelä ◽  
...  

AbstractThe paper studies what kind of support could be applied to the management of partly configurable modular systems. The main tasks of product management, product portfolio management and product variety management are defined. In addition, a partly configurable product structure and modular system are defined. Because the limited support in the literature for managing partly configurable modular systems, the article reviews previous product development cases in which authors have been involved on lessons learnt basis, i.e., if the methods and tools used in the cases could provide support for the research objective. As a result, the existing definition of the modular system should be extended by the concepts of non-module and design decision sequence description when dealing with partly configurable modular systems. This is because engineer-to-order should be made possible in cases where it brings clear added value to the customer compared to completely pre-defined solutions that may limit the customer's interest in the offering. Tools to assess the impact of changes to the product offering are required. These should be taken into account in frameworks that are used in method and tool development.



2002 ◽  
Vol 37 (1-2) ◽  
pp. 47-59
Author(s):  
Ishwar V. Hegde

This paper examines the implications of various agreements of WTO on Indian software industry. It also analyses recent developments in Indian software sector and provides new strategic options for the Industry. The study observes that the WTO agreements like GATT, GATS, TRIPS and IT will have profound implications on the software industry. It suggests that the robust growth of software industry during the last six years lies in many uneven patterns. Hence Indian companies need to supply patented software, provide high value solutions, expand their product portfolio to new destinations, and build Indian multinationals to negate the impact ofg lobal downturn and to reap the benefits of globalisation promoted by WTO.



2016 ◽  
Vol 17 (6) ◽  
pp. 1222-1236 ◽  
Author(s):  
Tomasz Brzęczek

Modern portfolio theory was applied to research product portfolio diversification. Prior research studies claimed a positive relationship between the number and variety of products and sales smoothing. However, they have also argued the limitations of classical portfolio analysis, especially owing to the assumption of independence of portfolio shares and the static nature of the approach. To address this limitation we extend the model to fit the trend and seasonality of sales, and to cover their correlations. The model aims to predict the impact of product width reduction on sales and their volatility. We consider the reduction of a product category in portfolio. The model covers the impact of product category sales on portfolio sales but also on other product category sales. Finally, we verify the model using a wholesaler company’s data and compare results. Hence, we recommend the model for the prediction of changes in sales and their volatility due to product category reduction. The model covers the portfolio dynamic approach to product width under the assumption of price taking, unlike in product assortment and variety planning models.



2004 ◽  
Vol 194 (9) ◽  
pp. 39-53
Author(s):  
Robert Ciborowski ◽  
Jerzy Grabowiecki


LOGOS ◽  
2017 ◽  
Vol 5 (1) ◽  
Author(s):  
Mag. Alfonso Cossio Carlín

RESUMENEl Objetivo General de la presente investigación es determinar el impacto que ha tenido el Tratado de Libre Comercio entre Perú y la Unión Europea en las exportaciones peruanas de mangos al Reino Unido (Inglaterra, Irlanda del Norte, Escocia y Gales). Las causas de dicho incremento no solamente se basan en un acceso preferencial (eliminación de aranceles de importación) sino también al aumento en el consumo de dicha fruta por parte de los residentes del Reino Unido. Este Tratado de Libre Comercio forma parte de una estrategia comercial integral que busca convertir al Perú en un país exportador, consolidando más mercados para su portafolio de productos, desarrollando una oferta exportable competitiva y promoviendo el comercio y la inversión, para brindar mayores oportunidades económicas y mejores niveles de vida.Por lo que en el presente artículo se presentan los siguientes ítems:IntroducciónMaterial y MétodoResultadosConclusionesBibliografíaPalabras claves: Tratado de Libre Comercio, consumo de mango, acceso preferencial.SUMMARYThe general objective of this research is to determine the impact that has had the Free Trade Agreement between Peru and the European Union in Peruvian exports of mangoes to the United Kingdom (England, Northern Ireland, Scotland and Wales). The causes of this increase not only rely on preferential access (elimination of import tariffs) but also to increased consumption of the fruit by UK residents.This FTA is part of a comprehensive business strategy that seeks to turn Peru into an exporter, consolidating more markets for its product portfolio, developing a competitive export supply and promoting trade and investment, to provide greater economic opportunities and improved living standards.So in this article, the following items are presented:• Introduction• Material and Methods• Results• Conclusions• BibliographyKeywords: Free Trade, consumption of mango, preferential access.



2020 ◽  
Vol 6 (4) ◽  
pp. 180
Author(s):  
Ibrahim Niankara

Nuclear power technology (NPT) perception and acceptance have globally emerged as the most critical questions for the successful integration of NPT into any national energy mix. In its combination with seawater desalination, NPT provides a sustainable alternative for the security and economic efficiency of both energy and fresh water supply, the latter of which has been identified as “the bloodstream of the biosphere”. Integrating econometric analysis into energy research with social science ramifications, this paper relies on bivariate ordered probit regression to study the impact of youths’ interests in the biosphere on their awareness and optimism toward NPT in the UAE. The model is estimated using maximum likelihood methods, with the results showing each level increase in UAE youths’ biospheric interests, to increase their NPT awareness by 13.5%, while conjointly reducing their optimistic expectations toward the technology by 2.4%. In addition, awareness and expectations about NPT are found to vary heterogeneously across the seven Emirates of the country. Moreover, accounting for all relevant factors (including respondents’ biospheric interests), formed expectations about NPT are not significantly shaped by NPT awareness. Given that the first unit of the UAE’s nuclear power plant “Barakah” just became operational in August 2020, our results provide important insights for evidence-based policy making to sustain the nascent nuclear energy program in the long run.



MBA Marketing ◽  
2014 ◽  
pp. 151-173
Author(s):  
Malcolm Mcdonald ◽  
Ailsa Kolsaker


2018 ◽  
Vol 46 (1) ◽  
pp. 5-9 ◽  
Author(s):  
Melanie Hingle ◽  
Heather Patrick ◽  
Paul M. Sacher ◽  
Cynthia Castro Sweet

A decade after the first health app became available, the field of digital health has produced a range of health behavior insights and an expanding product portfolio. Despite sustained interest and growth fueled by academic and industry interests, the impact of digital health on health behavior change and related outcomes has been limited. This underperformance relative to expectations may be partially attributed to a gap between industry and academia in which both seek to develop technology-driven solutions but fail to converge around respective, unique strengths. An opportunity exists for new and improved collaborative models of research, innovation, and care delivery that disrupt the field of behavioral medicine and benefit academic and industry interests. For those partnerships to thrive, recognizing key differences between academic and industry roles may help smooth the path. Here we speak specifically to concerns particular to academics and offer suggestions for how to navigate related challenges.



2014 ◽  
Vol 4 (3) ◽  
pp. 81-85
Author(s):  
Roberto Gambari

The β-thalassaemias are a group of severe and rare anaemias with monogenic inheritance, a complex systemic phenotype and several treatment-related complications, caused by more than 300 mutations of the β-globin gene. Novel therapeutic protocols, most of which are based on still experimental treatments, show great promise but significant variability of success between patients. These strategies include chemical/molecular induction of the endogenous β-like γ-globin gene or the restoration of clinically relevant β-globin levels by gene therapy. A small number of modifiers with significant impact on disease penetrance, severity and efficacy of treatments are known, but most remain elusive. Improvements of existing treatment regimens and optimization and application of novel treatments will critically depend on the characterization of additional disease modifiers and the stratification of patients for customized treatment regimens. This requires extensive analyses based on “OMICS”, an English-language neologism which refer to different but connected fields in molecular biology and biochemistry, such as genomics, transcriptomics, exomics, proteomics, metabolomics. The major objective of OMICS is a collective characterization of pools of biological molecules (gene sequences, transcripts, proteins and protein domains) controlling biological structures, functions and dynamics, including several involved in pathological conditions. One of the most interesting observations of genomics in β-thalassaemias is the association between genomic sequences and high fetal haemoglobin (HbF) levels, in consideration of the fact that high HbF levels are usually associated with milder forms of β-thalassaemia. Related to this issue, is the possibility to predict response to different therapeutic protocols on the basis of genomic analyses. For instance, three major loci (Xmn1-HBG2 single nucleotide polymorphism, HBS1L-MYB intergenic region on chromosome 6q, and BCL11A) contribute to high HbF production. Pharmacogenomic analysis of the effects of hydroxyurea (HU) on HbF production in a collection of β-thalassemia and sickle cell disease (SCD) patients allowed the identification of genomic signatures associated with high HbF. Therefore, it can hypothesized that genomic studies might predict the response of patients to treatments based on hydroxyurea, which is at present the most used HbF inducer in pharmacological therapy of β-thalassaemia. Transcriptomic/proteomic studies allowed to identify the zinc finger transcription factor B-cell lymphoma/leukemia 11A (BCL11A) as the major repressor of HbF expression. The field of research on g-globin gene repressors (including BCL11A) is of top interest, since several approaches can lead to pharmacologically-mediated inhibition of the expression of g-globin gene repressors, leading to gglobin gene activation. Among these strategies, we underline direct targeting of the transcription factors by aptamers or decoy molecules, as well as inhibition of the mRNA coding g-globin gene repressors with shRNAs, antisense molecules, peptide nucleic acids (PNAs) and microRNAs. In this respect, the THALAMOSS FP7 Project (THALAssaemia MOdular Stratification System for personalized therapy of β-thalassemia, www.thalamoss.eu) aims develop a universal sets of markers and techniques for stratification of β-thalassaemia patients into treatment subgroups for (a) onset and frequency of blood transfusions, (b) choice of iron chelation, (c) induction of fetal hemoglobin, (d) prospective efficacy of gene-therapy. The impact of THALAMOSS is the provision of novel biomarkers for distinct treatment subgroups in β-thalassaemia (500–1000 samples from participating medical centres), identified by combined genomics, proteomics, transcriptomics and tissue culture assays, the development of new or improved products for the cell isolation, characterization and treatment of β-thalassaemia patients and the establishment of routine techniques for detection of these markers and stratification of patients into treatment groups. Translation of these activities into the product portfolio and R&D methodology of participating SMEs will be a major boost for them as well as for the field. THALAMOSS tools and technologies will (a) facilitate identification of novel diagnostic tests, drugs and treatments specific to patient subgroups and (b) guide conventional and novel therapeutic approaches for β-thalassaemia, including personalized medical treatments.



Sign in / Sign up

Export Citation Format

Share Document